Seattle medical device firm EndoGastric Solutions closes $45M round for acid reflux treatment EndoGastric Solutions, a medical technology company focused on acid reflux, has closed a $45 million financing round to grow… Read More
EndoGastric Solutions raises $30.5M to commercialize acid reflux treatment News Brief: EndoGastric Solutions, a Seattle area biotechnology company, has raised $30.5 million to scale its commercial efforts. Existing investors… Read More
